Valeo Financial Advisors, LLC Ligand Pharmaceuticals Inc Transaction History

Valeo Financial Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 28, 2020	SELL	$89.56 - $126.72 $34,838 - $49,294	-389 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$68.28 - $123.65 $409 - $741	6 Added 1.57%	389 $44,000
Q4 2019 Jan 24, 2020	SELL	$96.94 - $113.59 $1,647 - $1,931	-17 Reduced 4.25%	383 $40,000
Q2 2019 Jul 10, 2019	BUY	$107.38 - $129.34 $42,952 - $51,736	400 New	400 $46,000
Q1 2019 Apr 12, 2019	SELL	$105.93 - $142.47 $2,436 - $3,276	-23 Closed	0 $0
Q4 2018 Jan 30, 2019	SELL	$128.36 - $272.13 $1,283 - $2,721	-10 Reduced 30.3%	23 $3,000
Q3 2018 Nov 01, 2018	SELL	$211.18 - $274.49 $211 - $274	-1 Reduced 2.94%	33 $6,000
Q1 2018 Apr 12, 2018	SELL	$138.63 - $182.62 $277 - $365	-2 Reduced 5.56%	34 $6,000
Q4 2017 Feb 09, 2018	BUY	$128.36 - $147.04 $4,620 - $5,293	36	36 $5,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.